Treatment > Daunorubicin


Cancer Chemother Pharmacol 1999;43(2):178-9. (Clinical Study)


Reference

Safety and potential effectiveness of daunorubicin-containing liposomes in patients with advanced recurrent malignant CNS tumors

Boiardi A, Pozzi A, Salmaggi A, Eoli M, Zucchetti M, Silvani A

Department of Neurology, National Neurological Institute C. Besta, Milan, Italy

 

PMID: 9923826 [PubMed - indexed for MEDLINE]

Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9923826&dopt=Abstract


 

HOME | Detection | Diagnosis | Epidemiology | Etiology & Pathogenesis | Integrative Medicine | Overall Mngt & Case Reports | Prevention | Prognosis | Psychosocial Aspects | Treatment 
About BrainLife
|
Children's Corner | E-mail Alerts | Journals | Newsletter | Patients & Caregivers | Search | Stem Cells | WHO Classification | SITEMAP